Parathyroid cancer treatment with immunotherapy

The main goal of immunotherapy is to enhance the patient's immune system and make it oppose cancer. Verification of the diagnosis is required to prevent any unnecessary therapy. As a result, the patients must undergo lab tests, examinations, and imaging procedures before starting immunotherapy. Mainly oncologists check for specific changes in the malignant cells to confirm that the immune drugs will be effective for a particular patient. Doctors might prescribe various medications to improve the patient's immune response, including parathyroid hormone treatment. Still, most often, immunotherapy became a part of adjuvant (an additional method of therapy) rather than a primary treatment method. By activating the patient's immune system, immunotherapy slows and reverses the growth and development of parathyroid malignant cells and creates an opportunity to use other treatment methods (mainly surgery). A single treatment procedure might take up to a few hours. Usually, the medications are delivered via droppers or intravenous infusions. In most cases, patients will need up to 6-10 treatment sessions to get a sustainable, steady result. Parathyroid cancer can be effectively treated even in the late 4th stages. However, combining this approach with other methods and careful patient selection is essential.